Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (Bone Marrow Transplantation, (2020), 10.1038/s41409-020-0919-0)

Creators: Ljungman P.; Mikulska M.; de la Camara R.; Basak G. W.; Chabannon C.; Corbacioglu S.; Duarte R.; Dolstra H.; Lankester A. C.; Mohty M.; Montoto S.; Murray J.; de Latour R. P.; Snowden J. A.; Yakoub-Agha I.; Verhoeven B.; Kroger N.; Styczynski J.

Others:: Ljungman, P.; Mikulska, M.; de la Camara, R.; Basak, G. W.; Chabannon, C.; Corbacioglu, S.; Duarte, R.; Dolstra, H.; Lankester, A. C.; Mohty, M.; Montoto, S.; Murray, J.; de Latour, R. P.; Snowden, J. A.; Yakoub-Agha, I.; Verhoeven, B.; Kroger, N.; Styczynski, J.

Description

The original HTML and PDF versions of this article were updated shortly after publication to correct author Bregje Verhoeven's name and affiliation. Bregje Verhoeven was incorrectly associated with Willem-Alexander Children's Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. The correct affiliation is Foundation Hematon, Utrecht, The Netherlands. This has now been corrected in both the PDF and HTML versions of the article.

Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (Bone Marrow Transplantation, (2020), 10.1038/s41409-020-0919-0)

Description

Additional details